Multi4

Multi4 is a company that specializes in endoscopic cancer diagnostics and treatment, specifically for urinary bladder cancer. They have developed a revolutionary and patented technology that automates the process, making it effortless and human-centric. The technology allows for local anesthesia, tissue sampling, transportation of samples, and the destruction of cancer tissue or stopping of bleedings, all in one instrument. Multi4's goal is to reduce human suffering and improve the quality of life for cancer patients. Additionally, their technology can also be applied to other types of cancer, such as esophagus, stomach, lungs, and intestines. The company is working on meeting regulatory requirements and plans to launch their product first in Sweden and later in Europe. They collaborate with research institutes and medical professionals to ensure the effectiveness and safety of their technology.